期刊文献+

N-乙酰半胱氨酸对老年冠心病患者介入治疗后造影剂肾病的预防作用 被引量:12

Preventive effect of N-acetylcysteine on contrast-induced nephropathy in elderly patients after percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨N-乙酰半胱氨酸(NAC)对老年冠心病患者PCI后造影剂肾病的预防作用。方法前瞻性入选天津市胸科医院心内科择期行PCI术的老年冠心病患者300例,按照随机数字表法分为NAC治疗组(NAC组)150例,常规治疗组(常规组)150例。其中NAC组给予NAC+水化治疗,常规组给予单纯水化治疗。观察2组患者PCI术前及术后72h血肌酐、肌酐清除率、尿素、β2微球蛋白(β2-MG)、C反应蛋白(CRP)、白细胞介素6(IL-6)、TNF-α、谷胱甘肽过氧化物酶(GPX)、超氧化物歧化酶(SOD)水平的变化,分析2组患者造影剂肾病发病情况。结果 NAC组与常规组PCI术后造影剂肾病发病率差异无统计学意义(P>0.05)。与术前比较,PCI术后72h,2组CRP、SOD、GPX水平明显升高(P<0.05),而2组血肌酐、肌酐清除率、尿素、IL-6、β2-MG比较,差异无统计学意义(P>0.05)。与常规组比较,PCI术后72h,NAC组SOD、GPX、CPR水平明显降低(P<0.01);而2组血肌酐、肌酐清除率、尿素、IL-6、β2-MG水平比较,差异无统计学意义(P>0.05)。结论 NAC对老年冠心病患者PCI术后造影剂肾病可能无预防作用。 Objective To study the preventive effect of N-acetylcysteine(NAC) on contrast-induced nephropathy in elderly patients with coronary heart disease(CHD) after percutaneous coronary intervention(PCI). Methods Three hundred elderly CHD patients admitted to Tianjin Chest Hospital for PCI were randomly divided into NAC treatment group(n= 150)and conventional treatment group(n=150). Patients in NAC treatment group received oral NAC+hydration treat- ment and those in conventional treatment group received simple hydration treatment. Their serum levels of creatinine (Scr), Scr clearance rate, urea nitrogen (BUN), β2 microglobulin (β2-MG), C-reactive protein(CRP), interleukin 6 (IL-6), tumor necrosis factor α(TNF-α), glutathione peroxidase(GPX) ,superoxide dismutase(SOD) were measured before and 72 h after PCI. Contrast-induced nephropathy in two groups was analyzed. Results No significant difference was found in the incidence of contrast-induced nephropathy between the two groups after PCI(P〈0.05). The serum levels of CRP, SOD and GPX were significantly higher in the two groups 72 h after PCI (P〉0.05) than before PCI. However, no significant difference was observed in the serum levels of Scr,CRP,BUN,β2-MG,IL-6,TNF-α,GPX,and SOD between the two group 72 h after PCI(P〉0.05). Conclusion NAC has no preventive effect on contrast-induced nephropathy in elderly CHD patients after PCI.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2013年第4期339-342,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 天津市卫生局科技基金(10KG122)
关键词 乙酰半胱氨酸 冠心病 造影剂 手术后并发症 肾病 , acetylcysteine coronary disease contrast media postoperative complications nephrosis
  • 相关文献

参考文献14

  • 1杨世诚,陈永利,刘园园,张莹莹,刘晓罡,付乃宽.经皮冠状动脉介入治疗术后对比剂肾病发病率及危险因素分析[J].天津医药,2011,39(10):903-906. 被引量:18
  • 2Brandes RP. Fleming I, Busse R. Endothelial aging. Cardio-vasc Res,2005,66 :286-294.
  • 3李法琪,司良毅.老年医学.北京:科学出版社,2002.217-218.
  • 4Shepherd J, Kastelein JJ, Bittne V,et al. Effect of intensivelipid lowering with atorvastatin on renal function in patientswith coronary heart disease: the treating to new targets(TNT) study. Clin J Am Soc Nephrol,2007 ,2 : 1131-1139.
  • 5Mehran R, Aymong E,Nikolsky E,et al. A simple risk scorefor prediction of CIN after percutaneous coronary interven-tion j developmen and innitial validation. J Am Coll Cardiol,2004,44:1393-1399.
  • 6李珊珊,杨世诚,陈永利,刘园园,刘晓罡,付乃宽.老年冠心病患者介入治疗术后对比剂肾损伤发生率及危险因素分析[J].中华老年心脑血管病杂志,2012,14(2):154-157. 被引量:16
  • 7Heyman SN, Rosen S, Khamaisi M,et al. Reactive oxygenspecies and the pathogenesis of radiocontrast-induced ne-phropathy. Invest Radiol,2010,45 : 188-195.
  • 8Saleh MA,Mahran OM’Bassam Al-Salahy M. Circulating ox-idative stress status in dromedary camels infested with sar-coptic mange. Vet Res Commun.2011,35 :35-45.
  • 9蔡文钦,苏津自,姚月娴,谢良地,杨月榕,陈秀平,王芳兵.超敏C蛋白对冠脉造影阴性患者术后短期肾功能的影响及阿托伐他汀干预作用[J].中国医学影像学杂志,2011,19(7):481-485. 被引量:3
  • 10Tepel M, van der Giet M,Schwarzfeld C, et al. Prevention ofradiographic contrast agent induced reductions in renal func-tion by acetylcysteine. N Engl J Med,2000,343 : 180-184.

二级参考文献28

  • 1刘润梅,夏云蜂,殷亚昕,翟红霞,李良.非离子造影剂对老年冠状动脉造影患者肾功能的影响[J].中华老年心脑血管病杂志,2006,8(3):180-183. 被引量:3
  • 2Toprak O. Risk markers for contrast induced nephropathy[J].Am J Med Sci, 2007,334(4):283-290.
  • 3Cho JY, Jeong MH, Hwan Park S,et al. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure[J]. J Cardiol,2010,56(3): 300-306.
  • 4Rosenstock JL, Gilles E, Geller AB,et al. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with- chronic kidney disease[J]. Int Urol Nephrol,2010,42(4):1049-1054.
  • 5Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction[J]. J Am Coll Cardiol, 2004,44(9):1780-1785.
  • 6Senoo T, Motohiro M, Kamihata H,et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome[J].Am J Cardiol, 2010, 105(5): 624-628.
  • 7Hernandez F, Mora L, Garcia-Tejada J,et al. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty[J].Rev Esp Cardiol, 2009, 62(12): 1373-1380.
  • 8Reed MC, Moscucci M, Smith DE,et al.The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) [J].J Invasive Cardiol,2010,22( 10):467-472.
  • 9McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol, 2008, 51(15): 1419-1428.
  • 10Barrett B J, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med, 2006, 354(4): 379-386.

共引文献34

同被引文献155

  • 1扆恒亮,谭宁,邓宇珺.N-乙酰半胱氨酸和碳酸氢钠预防中重度肾功能不全患者对比剂肾损害的作用[J].岭南心血管病杂志,2009,15(5):347-349. 被引量:4
  • 2丁晓隽,李慧华.急性冠状动脉综合征患者介入治疗中N-乙酰半胱氨酸对造影剂相关性肾病保护作用的临床研究[J].中华临床医师杂志(电子版),2011,5(15):4499-4501. 被引量:3
  • 3Zeinab Hegab,Stephen Gibbons,Ludwig Neyses,Mamas A Mamas,.在心血管的疾病的先进 glycation 结束产品的角色[J].World Journal of Cardiology,2012,4(4):90-102. 被引量:59
  • 4Yao-Min Hung,Shoa-Lin Lin,Shih-Yuan Hung,Paul Yung-Pou Wang.Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography[J].World Journal of Cardiology,2012,4(5):157-172. 被引量:13
  • 5STACUL F, MOLEM AJ, REIMER P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines[J]. Eur Radol, 2011, 21(12): 2527-2541.
  • 6FERRARIO F, BARONE MT, LANDONI G, et al. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy-a randomized controlled study[J]. Nepbrol Dial Transplant, 2009, 24(10): 3103-3107.
  • 7GOMES VO, FIGUREDO CEPD, CARAMORI P, et aL N-aeetylcysteine does not prevent contrast induced nephmpathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical triM[J]. Heart, 2005, 91(6): 774- 778.
  • 8OZCAN EE, GUNERI S, AKDENIZ B, et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures A single-center prospective controlled trial[J~ American Heart Journal, 2007, 154(3): 539-544.
  • 9BASKURT M, OKCUN B, ABACI O, et al. N-acetylcysteine versus N-acetylcysteine+theophylline for the prevention of contrast nephropathy[J]. European Journal of Clinical Investigation, 2009, 39(9): 793-799.
  • 10THIELE H, HILDEBRAND L, SCHIRDEWAHN C, et al. Impact of high-dose N-acetyIcysteine versus placebo on contrast induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J} Journal of the American College of Cardiology, 2010, 55(20): 2201-2209.

引证文献12

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部